Taurohyodeoxycholic Acid |
Katalog-Nr.GC41562 |
TaurohyodesoxycholsÄure ist die taurokonjugierte Form von HyodesoxycholsÄure (HDCA, eine dihydroxylierte natÜrliche GallensÄure).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2958/4/5
Sample solution is provided at 25 µL, 10mM.
Taurohyodeoxycholic acid (THDCA) is a taurine-conjugated form of the secondary bile acid hyodeoxycholic acid . THDCA decreases the size and weight of human gallstones in vitro. It increases bile flow, biliary cholesterol secretion, and biliary lipid secretion in rats. Co-administration of THDCA with taurochenodeoxycholic acid prevents TCDCA-induced hepatotoxicity, increasing bile flow as well as biliary acid and phospholipid secretion in rats. THDCA also reduces myeloperoxidase activity, expression of TNF-α and IL-6, and colonic damage in a mouse model of TNBS-induced ulcerative colitis.
Average Rating: 5
(Based on Reviews and 24 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *